Navigation Links
Argen-X Launches NHance™ Technology to Generate Better Human Antibody Therapies
Date:3/19/2012

ROTTERDAM, the Netherlands and GHENT, Belgium, March 19, 2012 /PRNewswire/ --

ADDS A SECOND PROPRIETARY TECHNOLOGY TO LEVERAGE THE POWER OF THE SIMPLE ANTIBODY™ PLATFORM  

arGEN-X announces today the launch of NHance™, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

NHance™ technology significantly prolongs the circulation time of therapeutic antibodies in the human body by engineering of the antibody constant region (Fc). The technology provides a new treatment paradigm in terms of reduced antibody dosing, increased efficacy and improved overall convenience to the patient.

Nhance™ is superior to existing Fc engineering approaches delivering superior pharmacokinetics without impairing the antibody's Fc-mediated cell-killing effects. The technology has been thoroughly validated, including through PK studies in appropriate pre-clinical models.

NHance™ is based on proprietary Fc region mutations and was invented by Dr. Sally Ward, Professor of Immunology at the University of Texas Southwestern Medical Center, a world renowned pioneer in this field of antibody biology. arGEN-X has acquired an exclusive global license to the technology.

arGEN-X will apply the NHance™ technology both to its partners' antibody discovery programs and to its own therapeutic antibody pipeline. In addition, arGEN-X intends to make the technology available to antibody-focused companies through non-exclusive licenses.

"Our validated SIMPLE Antibody™ platform, which delivers variable regions unrivalled in their functional diversity and therapeutic utility, is key to arGEN-X's success," says Prof. Dr. Hans de Haard, Chief Scientific Officer. "We had previously complemented the SIMPLE platform with state-of-the-art ADCC-enhancement through our Potelligent® license agreement with BioWa. We are now further strengthening our cu
'/>"/>

SOURCE arGEN-X
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round
2. arGEN-X Presents Significant Progress at BioPharm America 2011
3. arGEN-X Announces Non-Exclusive License With BioWa for POTELLIGENT® Technology
4. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
5. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
6. arGEN-X Concludes EUR 12.5 Million Series A Financing Round
7. New Restructuring Fund Launches for California Community Clinics
8. Ricky Gervais Launches Global Campaign to end Cosmetic Tests on Animals
9. UHC Launches RxLINK(TM) Mobile App to Deliver Instant Data Access for Strategic Pharmacy Purchasing
10. HRID Launches Plan to Expand Into World-Wide Market
11. Stryker Launches Next Generation Heavy Duty Surgical Power Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 Isis Pharmaceuticals, ... data from three drugs in its lipid franchise were ... of Cardiology (ESC) Congress in Barcelona Spain ... antisense drugs designed to provide effective and safe therapeutic ... is composed of one commercialized drug and several other ...
(Date:9/2/2014)... , Switzerland , September ... receiving ISO 13485 accreditation, Sophia Genetics has become the ... clinical use of a Next Generation Sequencing (NGS) ... certification represents an important step in raising the ... and brings Sophia Genetics, world-leading Data Driven Medicine ...
(Date:9/2/2014)... Sept. 2, 2014  Sinovac Biotech Ltd. (NASDAQ: ... China , today announced that the Company,s management ... , Morgan Stanley Global Healthcare Conference, to be held ... 10, 2014. , Morgan Stanley Asia Pacific Healthcare Day, ... 11, 2014. , Aegis Healthcare & Technology Conference, to ...
Breaking Medicine Technology:Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 3Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 4Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 5Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2Sinovac to Participate in Upcoming Investor Conferences 2
... (Nasdaq: ANTH ), a biopharmaceutical company developing ... autoimmune disorders, will release its first quarter 2012 financial ... Anthera will host a conference call at 8:30 am ... Conference Call Access: Date: Friday, May 4, 2012 Time: 8:30 ...
... for Disease Control reports annual deaths involving opioid pain ... in the United States. In New York and North ... abusing prescription medications continues to rise, sparking attention amongst ... care for those suffering from pain. For these reasons, ...
Cached Medicine Technology:Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 2Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 3Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 4
(Date:9/2/2014)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a forward-thinking ... Avon Health Center, a long-time NOVAtime 3000 customer ... Time and Attendance / Workforce Management solution ... the NT7000 . , Avon Health Center in ... nursing facility that provides short-term rehabilitation, long-term care, ...
(Date:9/2/2014)... “Harmonicas have been formally used in ... help people with COPD or asthma. At this ... says Dana Keller, PhD, co-inventor of the Pulmonica. ... much the same – improved health with the ... , The three approaches to harmonicas in healthcare ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... for women are long gone. But even though men shave ... an unhealthy appearance – rough and irritated skin isn’t inevitable, ... Advanced Dermatology P.C. , For decades, skin care ... years have witnessed a surge in men of all ages ...
(Date:9/2/2014)... September 02, 2014 AURO ... Canada announced today the expansion of its leadership team ... first Chief Financial Officer. Liang joins AURO in conjunction ... and will work closely with the operations, product management ... their cloud presence as well as ensuring effective internal ...
(Date:9/1/2014)... (PRWEB) September 02, 2014 BambooIndustry.com is ... products. The company is famous for its high quality ... the company has announced its new range of ... matter of fact, the company has confidence in the ... clients a huge selection of elegant bamboo items and ...
Breaking Medicine News(10 mins):Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3Health News:BambooIndustry.com: Solid Bamboo Floors Provided At Discounted Rates 2
... VIAP ), a biotechnology company focused on the ... today that,James G. Stewart, senior vice president, chief financial ... Susquehanna Second Annual SIGnificant,Options in Healthcare on Tuesday, March ... in New York. Interested parties may access a live ...
... You know that the HPV (human,papillomavirus) vaccine ... there a,theoretical basis for exploring its use in ... 3-part CME Webcast, assesses this,and other issues associated ... from Sexuality, Reproduction and Menopause (SRM), a clinical,publication ...
... SOUTH SAN FRANCISCO, Calif., Feb. 26 Rigel,Pharmaceuticals, ... it has named,Daniel B. Magilavy, M.D. vice president ... Magilavy will be responsible for the direction and,oversight ... and related autoimmune disorders. Rigel,s R788, oral syk ...
... EntreMed, Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical ... inflammatory diseases, today,announced that James S. Burns, President ... at the Jesup & Lamont Emerging Growth Stock,Conference, ... Resort in,Orlando, Florida on Thursday, February 28, 2008. ...
... /Xinhua-PRNewswire-FirstCall/ -- China Nepstar,Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the number ... entered into a definitive agreement to,acquire all of ... by Ningbo New Century Medical Ltd. ("New Century") ...
... XI,AN, China, Feb. 26 /Xinhua-PRNewswire-FirstCall/ -- China,Bionanometer ... company,within the bionanometer industry, will soon introduce ... of scientific verification, research and experiments,on the ... "Anti-influenza Oral,Granules" and the "Influenza Partner.", ...
Cached Medicine News:Health News:Experts Delve Into Issues of HPV Vaccination 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference 2Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 2Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 3Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 4Health News:China Bionanometer Industries Corporation Announces New Products for China 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: